IP Library Granted Patent US 7,615,376
Granted Patent B2
US 7,615,376 · App. 12/199,317 · Granted Nov 10, 2009

Masking background fluorescence and luminescence in the optical analysis of biomedical assays

Assignee: Bayer Schering Pharma Aktiengesellschaft
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,615,376
App. No.
12/199,317
Granted
Nov 10, 2009
Kind
B2
Abstract

In a process for the quantitative optical analysis of fluorescently labelled biological cells 5 , a cell layer on a transparent support at the bottom 2 of a reaction vessel 1 is in contact with a solution 3 containing the fluorescent dye 4 . The sensitivity of analytical detection can be considerably improved if to the fluorescent dye 4 already present in addition a masking dye 9 , which absorbs the excitation light 6 for the fluorescent dye 4 and/or its emission light 7 , is added to the solution 3 and/or if a separating layer 10 permeable to the solution and absorbing and/or reflecting the excitation light 6 or the emission light 7 is applied to the cell layer at the bottom 2 . This process can also be used for improving the sensitivity in the quantitative optical analysis of a luminescent biological cell layer. The separating layer 10 must in this case be composed such that it has a high power of reflection for the luminescent light 11 . Analogously, these process principles can also be used in receptor studies for the masking of the interfering background radiation in the quantitative optical analysis of fluorescently or luminescently labelled reaction components. In this case, a receptor layer 12 at the bottom 2 of a reaction vessel 1 is in contact with a solution (supernatant 3 ) in which a fluorescent or luminescent ligand 13 is dissolved. The sensitivity and accuracy of the analytical detection can be considerably improved here if a masking dye 9 which absorbs the excitation light 6 for the fluorescent dye and/or its emission light or (in the case of luminescent ligands) the luminescent light is added to the supernatant 3 . Instead of the masking dye in the solution 3 or optionally as an additional measure, a separating layer 10 permeable to the solution 3 and absorbing and/or reflecting the excitation light 6 and/or the emission light or the luminescent light can be applied to the cell or receptor layer 12 at the bottom 2.

Claims (6)

1. A process for the quantitative optical analysis of biological cells labeled with a fluorescent dye, the process comprising the following steps:

a) labeling a coherent layer of biological cells on a transparent support at the bottom of a reaction vessel with a fluorescent dye in a first solution;

b) shining excitation energy through the transparent support to cause the biological cells labeled with said fluorescent dye to exhibit fluorescence in the presence of a second solution comprising said fluorescent dye and a masking dye absorbing at least one of:

i) the excitation energy of said fluorescent dye in the second solution; and

ii) the emission light of said fluorescent dye in the second solution; and

c) detecting the fluorescence of the biological cells labeled with said fluorescent dye through the transparent support.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2016
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 039756/0128 →
A CHANGE OF NAME WAS RECORDED ON AUGUST 28, 2009 AT REEL/FRAME 023148/0924. THE ADDRESS SHOULD ALSO HAVE BEEN CHANGE FROM LEVERKUSEN GERMANY 51368 TO BERLIN, GERMANY 13353 Recorded Sep 13, 2010
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 024973/0737 →
CHANGE OF NAME Recorded Aug 28, 2009
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 023148/0924 →
Priority Claims (1)
DE 196 21 312 · May 28, 1996 · national
Continuity (3)
Division 0996655200 · Sep 28, 2001
Continuation 0919409900
Related Publication 20080318270A1 · Dec 25, 2008